In a mouse model of AD, central or peripheral treatment with leptin restores diminished phosphorylation of Akt in the hippocampus, reduces neuronal loss, and improves deficiencies in spatial learning and memory (39, 40). This evidence concerns the gene AKT1 and Alzheimer disease.